Pell Bio-Med Technology Co., Ltd. (TPE:6949)

Pell Bio-Med Technology Statistics

Total Valuation

TPE:6949 has a market cap or net worth of TWD 22.14 billion. The enterprise value is 21.94 billion.

Market Cap	22.14B
Enterprise Value	21.94B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6949 has 58.57 million shares outstanding. The number of shares has increased by 6.22% in one year.

Current Share Class	58.57M
Shares Outstanding	58.57M
Shares Change (YoY)	+6.22%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	15.14%
Owned by Institutions (%)	0.16%
Float	29.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	738.20
PB Ratio	17.94
P/TBV Ratio	23.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-58.71
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-38.38

Financial Position

The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.20.

Current Ratio	3.49
Quick Ratio	2.71
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	-81.15

Financial Efficiency

Return on equity (ROE) is -29.79% and return on invested capital (ROIC) is -16.52%.

Return on Equity (ROE)	-29.79%
Return on Assets (ROA)	-15.42%
Return on Invested Capital (ROIC)	-16.52%
Return on Capital Employed (ROCE)	-29.63%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	6.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +342.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+342.11%
50-Day Moving Average	380.15
200-Day Moving Average	242.64
Relative Strength Index (RSI)	52.21
Average Volume (20 Days)	105,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6949 had revenue of TWD 29.99 million and -373.72 million in losses. Loss per share was -6.39.

Revenue	29.99M
Gross Profit	-9.33M
Operating Income	-400.15M
Pretax Income	-389.08M
Net Income	-373.72M
EBITDA	-381.01M
EBIT	-400.15M
Loss Per Share	-6.39

Balance Sheet

The company has 720.23 million in cash and 244.20 million in debt, giving a net cash position of 476.03 million or 8.13 per share.

Cash & Cash Equivalents	720.23M
Total Debt	244.20M
Net Cash	476.03M
Net Cash Per Share	8.13
Equity (Book Value)	1.23B
Book Value Per Share	16.34
Working Capital	671.83M

Cash Flow

In the last 12 months, operating cash flow was -268.64 million and capital expenditures -303.12 million, giving a free cash flow of -571.76 million.

Operating Cash Flow	-268.64M
Capital Expenditures	-303.12M
Free Cash Flow	-571.76M
FCF Per Share	-9.76

Margins

Gross Margin	-31.12%
Operating Margin	-1,334.16%
Pretax Margin	-1,297.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6949 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.22%
Shareholder Yield	-6.22%
Earnings Yield	-1.69%
FCF Yield	-2.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:6949 has an Altman Z-Score of 13.44 and a Piotroski F-Score of 3.

Altman Z-Score	13.44
Piotroski F-Score	3